about
Joint analysis of multiple high-dimensional data types using sparse matrix approximations of rank-1 with applications to ovarian and liver cancerCushing's syndrome caused by an ACTH-producing large cell neuroendocrine carcinoma of the gallbladder.Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT.Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging.Demographic, treatment, and survival patterns for Native Hawaiians with lung cancer treated at a community medical center from 1995 to 2001.Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.Cancer imaging with fluorine-18-labeled choline derivatives.Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral statusViral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CTPositron emission tomography in hepatobiliary and pancreatic malignancies: a review.Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome.Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysisChanges in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT.Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.(18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.[18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling.Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels.Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer.Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.Soft Tissue Response on 18F-Fluorocholine PET/CT in Metastatic Castrate-Resistant Prostate Cancer Treated With 223Ra-Dichloride: A Possible Abscopal Effect?Pararenal splenosis encountered during the evaluation of a suspected pheochromocytoma.Positron emission tomography study of voluntary saccadic eye movements and spatial working memory.Occupational exposures and knowledge of universal precautions among medical studentsThe impact of urinary excretion of (18)F-labeled choline analogsLate recurrence of hepatocellular carcinoma after liver transplantationPhospholipids are A Potentially Important Source of Tissue Biomarkers for Hepatocellular Carcinoma: Results of a Pilot Study Involving Targeted MetabolomicsTranscriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
P50
Q28595658-C5F1DD27-D972-43B2-9B76-EEC5DE7F3F94Q34391052-2640AB1F-1C50-45C2-B759-655266D931F1Q34447257-B137CB65-8059-4B4F-A878-C9A8B33387BDQ34598189-7C25EA69-32FF-423D-A415-33794D965BD1Q35515150-C8B6B2BE-B69F-487C-B7D5-3182A647EF4CQ35582133-66CD484B-B7D2-4953-B65C-73E366DA7B52Q35747156-6634C7C8-87A8-4BA0-868F-BA1D5ACE3D19Q36103698-188B2FF1-603D-4F2E-A531-568E39B9020FQ36310823-9BEDDA67-5139-4ED8-B4C1-4D31213DF3B4Q36568339-D85F47A5-91EC-4389-9276-6B00FA0D87A5Q36962886-CAE6C861-1A1C-4F23-B4C7-DA87C0DAA231Q37082686-98BFC6AE-52A8-450A-B382-4B6109E6EF81Q37281965-A4291A05-0DBC-4DB4-B6A4-ABA0AC2F1775Q37496697-1168182D-7B8B-4C09-8835-F2F85CB1DC53Q37998654-83390B6C-B468-4414-AB4F-9010AB152689Q40135381-50E6340A-848E-44C3-B354-6D98BCEDA079Q40960892-14812881-004B-483F-84B5-956D08D17E27Q41447911-F400C0EA-6961-43AC-8C8C-3B080015589AQ42364439-CF4EB8E2-95F2-4682-A2C5-A35FFA2E42BFQ42530668-6ABFC1FF-A8EE-4FC5-9576-D658F2B8FDA0Q43187966-F1960AC3-961B-4032-84D8-BB2FEBDA45CFQ44959942-03AE2D11-8D17-40EE-9909-9835B684DB8AQ45183432-A5FE25CF-7525-4B78-8F6E-F69D67D2CC82Q45967819-AB059E53-251F-41E7-BBC3-AC3E0D632FC7Q46469807-B3C8ECBE-1AE3-4196-8FDA-E7A6C491A761Q46561461-30949895-C00C-4734-A040-38E647C3AF57Q46667718-CB6B3BEE-626B-4931-8123-3D518FA3BB48Q46925555-65A6CA2F-3C82-475D-8E10-FC998C4504EEQ48284532-35316E32-6377-4A69-99D2-48F8889A7178Q50223054-50A4A0C8-D1E8-4935-A47E-D20B037CD4CEQ50563584-ED622B76-0390-4979-B488-840DE07C9BAFQ52010943-53A3639E-07BD-49AF-A65C-4E6AF4AC48ECQ74656782-2201B3C5-9BEF-47FC-B59D-AB4F9A396F04Q80558442-02665FCF-1EA4-420A-AAFD-14AFA425CCC1Q89116653-D38B252A-47F9-415E-B224-E32B44FC689DQ91038563-1EAAC44D-A695-4389-9E6A-541066DB1C19Q91556407-1CDD1F05-0946-44E4-ABCE-A0DAF733E35B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sandi Kwee
@ast
Sandi Kwee
@en
Sandi Kwee
@es
Sandi Kwee
@nl
Sandi Kwee
@sl
type
label
Sandi Kwee
@ast
Sandi Kwee
@en
Sandi Kwee
@es
Sandi Kwee
@nl
Sandi Kwee
@sl
prefLabel
Sandi Kwee
@ast
Sandi Kwee
@en
Sandi Kwee
@es
Sandi Kwee
@nl
Sandi Kwee
@sl
P106
P31
P496
0000-0002-4624-8787